The efficacy and safety of sequential use of anlotinib and 131I for locally advanced or metastatic differentiated thyroid cancer: A single-arm phase II clinical trial

被引：0
|
作者：
Song, Hongjun
Qiu, Xian
He, Ziyan
Chen, Libo
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 6, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Peoples Hosp 6, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18102
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The efficacy and safety of lenvatinib in neoadjuvant therapy in patients with locally advanced thyroid cancer: A singlearm phase II clinical trial
    Yu, J.
    Wu, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S1147 - S1147
  • [22] First-Line Treatment of Locally Advanced or Metastatic Pulmonary Lymphoepitheliomalikecarcinoma: A Multicenter, Single-Arm, Phase II Trial
    Zhou, C.
    Lin, X.
    Li, S.
    Sun, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S96 - S97
  • [23] Perioperative penpulimab plus anlotinib combined with chemotherapy for locally advanced gastric cancer: A single arm, multicenter, phase II clinical trial.
    Wang, Mian
    Zhou, Wei
    Miao, Yan
    Tan, Zhaobang
    Li, Yiding
    Hong, Liu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS485 - TPS485
  • [24] Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
    Li, Huihui
    Tan, Qiaorui
    Sun, Shujuan
    Zhou, Dongdong
    Yu, Bo
    Su, Mu
    Li, Baojiang
    Fang, Shu
    Qiang, Ling
    Ren, Guohua
    Bu, Bing
    Yin, Sha
    Man, Xiaochu
    Qiu, Pengfei
    Wang, Xinzhao
    Li, Chao
    Cao, Fangli
    Shao, Qian
    Han, Dali
    Song, Lihua
    Fan, Bingjie
    Zhang, Baoxuan
    Xu, Liang
    Zhao, Xianguang
    Liao, Yuqian
    Xie, Xuemei
    Liu, Lanping
    CANCER RESEARCH, 2023, 83 (05)
  • [25] Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial
    Guo, Honghai
    Ding, Ping'an
    Sun, Chenyu
    Yang, Peigang
    Tian, Yuan
    Liu, Yang
    Lowe, Scott
    Bentley, Rachel
    Li, Yaru
    Zhang, Zhidong
    Wang, Dong
    Li, Yong
    Zhao, Qun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): preliminary results of a single-arm, multicenter phase II trial
    Li, Huihui
    Zhou, Dongdong
    Yv, Zeshun
    Liao, Yuqian
    Huang, Jie
    Sun, Shujuan
    Zheng, Fangchao
    Li, Baojiang
    Fang, Shu
    Qiang, Ling
    Ren, Guohua
    Bu, Bing
    Qiu, Pengfei
    Wang, Xinzhao
    Li, Chao
    Cao, Fangli
    Shao, Qian
    Han, Dali
    Song, Lihua
    Zhang, Baoxuan
    Fan, Bingjie
    Xu, Liang
    Xie, Xuemei
    Zhao, Xianguang
    Liu, Lanping
    Li, Wanlong
    Wang, Zhenbo
    Liu, Changmin
    Fu, Hui
    Sun, Xiao
    Shi, Zhiqiang
    Li, Fengxiang
    CANCER RESEARCH, 2024, 84 (09)
  • [27] Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
    Chi, Yihebali
    Zheng, Xiangqian
    Zhang, Yuan
    Shi, Feng
    Cheng, Ying
    Guo, Zhuming
    Ge, Minghua
    Qin, Jianwu
    Zhang, Jiewu
    Li, Zhendong
    Zhou, Xiaohong
    Huang, Rui
    Chen, Xiaohong
    Liu, Hui
    Cheng, Ruochuan
    Xu, Zhengang
    Li, Dapeng
    Tang, Pingzhang
    Gao, Ming
    CLINICAL CANCER RESEARCH, 2023, 29 (20) : 4047 - 4056
  • [28] Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trial
    Li, H.
    Zhou, D.
    Yv, Z.
    Liao, Y.
    Huang, J.
    Sun, S.
    Zheng, F.
    Li, B.
    Fang, S.
    Qiang, L.
    Ren, G.
    Wang, X.
    Baoxuan, Z.
    Fan, B.
    Zhao, X.
    Li, W.
    Wang, Z.
    Fu, H.
    Sun, X.
    Shi, Z.
    ANNALS OF ONCOLOGY, 2024, 35 : S381 - S381
  • [29] Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial
    Chi, Y.
    Gao, M.
    Zhang, Y.
    Shi, F.
    Cheng, Y.
    Guo, Z.
    Ge, M.
    Qin, J.
    Zhang, J.
    Li, Z.
    Zhou, X.
    Huang, R.
    Chen, X.
    Liu, H.
    Cheng, R.
    Xu, Z.
    Zheng, X.
    Li, D.
    Tang, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S1215 - S1215
  • [30] A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma
    Ingham, Matthew
    Lee, Shing
    Tine, Brian A. Van
    Choy, Edwin
    Oza, Jay
    Doshi, Sahil
    Ge, Liner
    Oppelt, Peter
    Cote, Gregory
    Corgiat, Brian
    Sender, Naomi
    Ana, Sarah Sta
    Panchalingam, Lavan
    Petricoin, Emmanuel
    Schwartz, Gary K.
    CLINICAL CANCER RESEARCH, 2023, 29 (06) : 1031 - 1039
12345